Bank of America (BofA) has turned bullish on several high-growth companies across technology, healthcare, and retail sectors, raising price targets and reaffirming strong growth expectations.
MongoDB (MDB) Stock Price Target Raised by BofA
Bank of America has reaffirmed its Buy rating on MongoDB and raised its price target from $375 to $390. Analysts see MongoDB steadily capturing more share in the next-gen database space.
The firm noted that MongoDB’s latest results and raised FY2027 revenue outlook—between $2.92 billion and $2.96 billion—point to stronger customer demand and improving usage patterns.
BofA also observed that the guidance hike exceeded the quarterly earnings beat itself, reflecting confidence in sustained long-term growth. MongoDB is increasingly viewed as a key winner of the AI-fueled cloud database surge, as enterprises keep embracing modern database infrastructure solutions.
Eli Lilly (LLY) Stock Receives Major Price Target Boost
Bank of America also issued a bullish update on Eli Lilly, raising its price target from $1,133 to $1,251 while keeping a Buy rating.
Analyst Jason Gerberry pointed to Lilly’s leading role in the fast-growing GLP-1 obesity drug market as the main driver. A recent BofA physician survey shows doctors anticipate rising GLP-1 use in the coming years.
BofA now projects the U.S. GLP-1 market will grow from roughly $35 billion in 2026 to nearly $79 billion by 2033. Lilly is expected to capture much of this growth through its expanding obesity and diabetes pipeline. Strong demand for weight-loss drugs and future launches keep Lilly a top pharma growth story on Wall Street.
BofA Initiates Buy Rating on Lenskart
Bank of America initiated coverage on Lenskart with a Buy rating, citing its scalable tech-driven model and strong long-term growth potential. BofA analysts note India’s prescription eyewear market remains deeply underpenetrated: nearly 50% of Indians need vision correction, but only about 35% use prescription eyewear, presenting a huge opportunity for Lenskart.
The brokerage praised Lenskart’s integrated operations, efficient supply chain, and rapid store expansion, with most stores recovering investment in under one year and small-town locations showing even better returns.
BofA expects revenue growth and operating leverage to expand pre-IndAS EBITDA margins to 14% by FY28, with a long-term goal of 25%. The firm added that Lenskart’s model scales globally, backed by a strong balance sheet to fund future tech, store, and manufacturing investments.
